secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALISADE BIO, INC. (PALI)
CIK:        0001357459
Form:       8-K
Filed at:   2022-06-10T23:59:59+00:00
Accession:  0000950170-22-011498
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Palisade Bio shareholders elect two Class II directors and ratify auditor at 2022 annual meeting
--------------------------------------------------------------------------------

- Election of Donald Williams and Robert J. Trenschel as Class II directors to serve until 2025.
- Ratification of BDO USA as independent auditor for FY2022 with 8,731,767 votes for.
- Advisory approval of named executive officer compensation passed with 3,765,654 votes for.
- 10,123,515 shares present (55.52% of outstanding); quorum achieved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357459/000095017022011498/0000950170-22-011498-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357459/000095017022011498/pali-20220609.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-011498

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer